These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 32346029)

  • 21. In vitro activity of the siderophore monosulfactam BAL30072 against contemporary Gram-negative pathogens from New York City, including multidrug-resistant isolates.
    Landman D; Singh M; El-Imad B; Miller E; Win T; Quale J
    Int J Antimicrob Agents; 2014 Jun; 43(6):527-32. PubMed ID: 24796217
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro time-kill studies of antimicrobial agents against blood isolates of imipenem-resistant Acinetobacter baumannii, including colistin- or tigecycline-resistant isolates.
    Peck KR; Kim MJ; Choi JY; Kim HS; Kang CI; Cho YK; Park DW; Lee HJ; Lee MS; Ko KS
    J Med Microbiol; 2012 Mar; 61(Pt 3):353-360. PubMed ID: 22016557
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evaluation of the in vitro activity of new polymyxin B analogue SPR206 against clinical MDR, colistin-resistant and tigecycline-resistant Gram-negative bacilli.
    Zhang Y; Zhao C; Wang Q; Wang X; Chen H; Li H; Zhang F; Wang H
    J Antimicrob Chemother; 2020 Sep; 75(9):2609-2615. PubMed ID: 32591806
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Evaluation of Colistin-Ampicillin/Sulbactam Combination Efficacy in Imipenem-Resistant Acinetobacter baumannii Strains].
    Cıkman A; Ceylan MR; Parlak M; Karahocagil MK; Berktaş M
    Mikrobiyol Bul; 2013 Jan; 47(1):147-51. PubMed ID: 23390912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. In vitro activity of daptomycin in combination with low-dose colistin against a diverse collection of Gram-negative bacterial pathogens.
    Phee L; Hornsey M; Wareham DW
    Eur J Clin Microbiol Infect Dis; 2013 Oct; 32(10):1291-4. PubMed ID: 23609511
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Emergence of the Novel Aminoglycoside Acetyltransferase Variant
    Sato T; Wada T; Nishijima S; Fukushima Y; Nakajima C; Suzuki Y; Takahashi S; Yokota SI
    mBio; 2020 Dec; 11(6):. PubMed ID: 33443109
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Polymyxin combination therapy for multidrug-resistant, extensively-drug resistant, and difficult-to-treat drug-resistant gram-negative infections: is it superior to polymyxin monotherapy?
    Ardebili A; Izanloo A; Rastegar M
    Expert Rev Anti Infect Ther; 2023 Apr; 21(4):387-429. PubMed ID: 36820511
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Resveratrol Increases Sensitivity of Clinical Colistin-Resistant Pseudomonas aeruginosa to Colistin
    Wang L; Zhang Y; Lin Y; Cao J; Xu C; Chen L; Wang Y; Sun Y; Zheng X; Liu Y; Zhou T
    Microbiol Spectr; 2023 Feb; 11(1):e0199222. PubMed ID: 36475724
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CSA-131, a ceragenin active against colistin-resistant Acinetobacter baumannii and Pseudomonas aeruginosa clinical isolates.
    Vila-Farrés X; Callarisa AE; Gu X; Savage PB; Giralt E; Vila J
    Int J Antimicrob Agents; 2015 Nov; 46(5):568-71. PubMed ID: 26395218
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LysSAP26, a New Recombinant Phage Endolysin with a Broad Spectrum Antibacterial Activity.
    Kim S; Jin JS; Choi YJ; Kim J
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33238548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.
    Bae S; Kim MC; Park SJ; Kim HS; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6774-6779. PubMed ID: 27600048
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antimicrobial activity of LysSS, a novel phage endolysin, against Acinetobacter baumannii and Pseudomonas aeruginosa.
    Kim S; Lee DW; Jin JS; Kim J
    J Glob Antimicrob Resist; 2020 Sep; 22():32-39. PubMed ID: 32006750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circumventing colistin resistance by combining colistin and antimicrobial peptides to kill colistin-resistant and multidrug-resistant Gram-negative bacteria.
    Witherell KS; Price J; Bandaranayake AD; Olson J; Call DR
    J Glob Antimicrob Resist; 2020 Sep; 22():706-712. PubMed ID: 32512236
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro efficacy of colistin against multi-drug resistant Pseudomonas aeruginosa by minimum inhibitory concentration.
    Gill MM; Rao JU; Kaleem F; Hassan A; Khalid A; Anjum R
    Pak J Pharm Sci; 2013 Jan; 26(1):7-10. PubMed ID: 23261721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Rapid antimicrobial susceptibility test for identification of new therapeutics and drug combinations against multidrug-resistant bacteria.
    Sun W; Weingarten RA; Xu M; Southall N; Dai S; Shinn P; Sanderson PE; Williamson PR; Frank KM; Zheng W
    Emerg Microbes Infect; 2016 Nov; 5(11):e116. PubMed ID: 27826141
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro synergistic activity of colistin and teicoplanin combination against multidrug-resistant Acinetobacter spp.
    Rady OMSM; El-Attar L; Amine A
    J Antibiot (Tokyo); 2022 Mar; 75(3):181-184. PubMed ID: 35091666
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro activities of colistin, imipenem and ceftazidime against drug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii isolates in the south of Iran.
    Malekzadegan Y; Abdi A; Heidari H; Moradi M; Rastegar E; Sedigh Ebrahim-Saraie H
    BMC Res Notes; 2019 May; 12(1):301. PubMed ID: 31138309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibacterial activity of vB_AbaM_PhT2 phage hydrophobic amino acid fusion endolysin, combined with colistin against Acinetobacter baumannii.
    Sitthisak S; Manrueang S; Khongfak S; Leungtongkam U; Thummeepak R; Thanwisai A; Burton N; Dhanoa GK; Tsapras P; Sagona AP
    Sci Rep; 2023 May; 13(1):7470. PubMed ID: 37156803
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In vivo activity of co-trimoxazole combined with colistin against Acinetobacter baumannii producing OXA-23 in a Galleria mellonella model.
    Khalil MAF; Moawad SS; Hefzy EM
    J Med Microbiol; 2019 Jan; 68(1):52-59. PubMed ID: 30422109
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synergism of colistin and globular endolysins against multidrug-resistant gram-negative bacteria.
    Zhang P; Zeng P; Lai CKC; Ip M; To KKW; Zuo Z; Xia J; Leung SSY
    Int J Biol Macromol; 2024 Oct; 278(Pt 2):134670. PubMed ID: 39151868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.